FDA Approves Mulpleta

On July 31, 2018, the Food and Drug Administration approved lusutrombopag (Mulpleta, Shionogi Inc.) for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a
Read More

FDA Approves Perseris

SLOUGH, England and RICHMOND, Va., July 27, 2018 /PRNewswire/ — Indivior PLC (LON: INDV) today announced that the U.S. Food and Drug Administration (FDA) has approved Perseris, the
Read More